Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis.
Evangelos KatsarogiannisAnne-Marie LandtblomAnna KristofferssonJohan WikströmRobert SemnicShala Ghaderi BerntssonPublished in: Journal of clinical medicine (2023)
= 0.001). The overall misdiagnosis rate in the cohort was 33%, with 22% of misdiagnosed patients having received DMTs. (4) Conclusions: Our results confirm that the absence of OCB in the CSF should raise suspicion of possible misdiagnosis in MS patients and prompt a diagnostic reassessment.